2022-10-012023-09-302023-09-30false10383691GDK MEDI UK LTD2024-03-01iso4217:GBPxbrli:pure103836912022-10-01103836912023-09-30103836912022-10-012023-09-30103836912021-10-01103836912022-09-30103836912021-10-012022-09-3010383691bus:SmallEntities2022-10-012023-09-3010383691bus:AuditExempt-NoAccountantsReport2022-10-012023-09-3010383691bus:AbridgedAccounts2022-10-012023-09-3010383691bus:PrivateLimitedCompanyLtd2022-10-012023-09-3010383691core:WithinOneYear2023-09-3010383691core:AfterOneYear2023-09-3010383691core:WithinOneYear2022-09-3010383691core:AfterOneYear2022-09-3010383691core:ShareCapital2023-09-3010383691core:SharePremium2023-09-3010383691core:RevaluationReserve2023-09-3010383691core:OtherReservesSubtotal2023-09-3010383691core:RetainedEarningsAccumulatedLosses2023-09-3010383691core:ShareCapital2022-09-3010383691core:SharePremium2022-09-3010383691core:RevaluationReserve2022-09-3010383691core:OtherReservesSubtotal2022-09-3010383691core:RetainedEarningsAccumulatedLosses2022-09-3010383691core:LandBuildings2023-09-3010383691core:PlantMachinery2023-09-3010383691core:Vehicles2023-09-3010383691core:FurnitureFittings2023-09-3010383691core:OfficeEquipment2023-09-3010383691core:NetGoodwill2023-09-3010383691core:IntangibleAssetsOtherThanGoodwill2023-09-3010383691core:ListedExchangeTraded2023-09-3010383691core:UnlistedNon-exchangeTraded2023-09-3010383691core:LandBuildings2022-09-3010383691core:PlantMachinery2022-09-3010383691core:Vehicles2022-09-3010383691core:FurnitureFittings2022-09-3010383691core:OfficeEquipment2022-09-3010383691core:NetGoodwill2022-09-3010383691core:IntangibleAssetsOtherThanGoodwill2022-09-3010383691core:ListedExchangeTraded2022-09-3010383691core:UnlistedNon-exchangeTraded2022-09-3010383691core:LandBuildings2022-10-012023-09-3010383691core:PlantMachinery2022-10-012023-09-3010383691core:Vehicles2022-10-012023-09-3010383691core:FurnitureFittings2022-10-012023-09-3010383691core:OfficeEquipment2022-10-012023-09-3010383691core:NetGoodwill2022-10-012023-09-3010383691core:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3010383691core:ListedExchangeTraded2022-10-012023-09-3010383691core:UnlistedNon-exchangeTraded2022-10-012023-09-3010383691core:MoreThanFiveYears2022-10-012023-09-3010383691core:Non-currentFinancialInstruments2023-09-3010383691core:Non-currentFinancialInstruments2022-09-3010383691dpl:CostSales2022-10-012023-09-3010383691dpl:DistributionCosts2022-10-012023-09-3010383691core:LandBuildings2022-10-012023-09-3010383691core:PlantMachinery2022-10-012023-09-3010383691core:Vehicles2022-10-012023-09-3010383691core:FurnitureFittings2022-10-012023-09-3010383691core:OfficeEquipment2022-10-012023-09-3010383691dpl:AdministrativeExpenses2022-10-012023-09-3010383691core:NetGoodwill2022-10-012023-09-3010383691core:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3010383691dpl:GroupUndertakings2022-10-012023-09-3010383691dpl:ParticipatingInterests2022-10-012023-09-3010383691dpl:GroupUndertakingscore:ListedExchangeTraded2022-10-012023-09-3010383691core:ListedExchangeTraded2022-10-012023-09-3010383691dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-10-012023-09-3010383691core:UnlistedNon-exchangeTraded2022-10-012023-09-3010383691dpl:CostSales2021-10-012022-09-3010383691dpl:DistributionCosts2021-10-012022-09-3010383691core:LandBuildings2021-10-012022-09-3010383691core:PlantMachinery2021-10-012022-09-3010383691core:Vehicles2021-10-012022-09-3010383691core:FurnitureFittings2021-10-012022-09-3010383691core:OfficeEquipment2021-10-012022-09-3010383691dpl:AdministrativeExpenses2021-10-012022-09-3010383691core:NetGoodwill2021-10-012022-09-3010383691core:IntangibleAssetsOtherThanGoodwill2021-10-012022-09-3010383691dpl:GroupUndertakings2021-10-012022-09-3010383691dpl:ParticipatingInterests2021-10-012022-09-3010383691dpl:GroupUndertakingscore:ListedExchangeTraded2021-10-012022-09-3010383691core:ListedExchangeTraded2021-10-012022-09-3010383691dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-10-012022-09-3010383691core:UnlistedNon-exchangeTraded2021-10-012022-09-3010383691core:NetGoodwill2023-09-3010383691core:IntangibleAssetsOtherThanGoodwill2023-09-3010383691core:LandBuildings2023-09-3010383691core:PlantMachinery2023-09-3010383691core:Vehicles2023-09-3010383691core:FurnitureFittings2023-09-3010383691core:OfficeEquipment2023-09-3010383691core:AfterOneYear2023-09-3010383691core:WithinOneYear2023-09-3010383691core:ListedExchangeTraded2023-09-3010383691core:UnlistedNon-exchangeTraded2023-09-3010383691core:ShareCapital2023-09-3010383691core:SharePremium2023-09-3010383691core:RevaluationReserve2023-09-3010383691core:OtherReservesSubtotal2023-09-3010383691core:RetainedEarningsAccumulatedLosses2023-09-3010383691core:NetGoodwill2022-09-3010383691core:IntangibleAssetsOtherThanGoodwill2022-09-3010383691core:LandBuildings2022-09-3010383691core:PlantMachinery2022-09-3010383691core:Vehicles2022-09-3010383691core:FurnitureFittings2022-09-3010383691core:OfficeEquipment2022-09-3010383691core:AfterOneYear2022-09-3010383691core:WithinOneYear2022-09-3010383691core:ListedExchangeTraded2022-09-3010383691core:UnlistedNon-exchangeTraded2022-09-3010383691core:ShareCapital2022-09-3010383691core:SharePremium2022-09-3010383691core:RevaluationReserve2022-09-3010383691core:OtherReservesSubtotal2022-09-3010383691core:RetainedEarningsAccumulatedLosses2022-09-3010383691core:NetGoodwill2021-10-0110383691core:IntangibleAssetsOtherThanGoodwill2021-10-0110383691core:LandBuildings2021-10-0110383691core:PlantMachinery2021-10-0110383691core:Vehicles2021-10-0110383691core:FurnitureFittings2021-10-0110383691core:OfficeEquipment2021-10-0110383691core:AfterOneYear2021-10-0110383691core:WithinOneYear2021-10-0110383691core:ListedExchangeTraded2021-10-0110383691core:UnlistedNon-exchangeTraded2021-10-0110383691core:ShareCapital2021-10-0110383691core:SharePremium2021-10-0110383691core:RevaluationReserve2021-10-0110383691core:OtherReservesSubtotal2021-10-0110383691core:RetainedEarningsAccumulatedLosses2021-10-0110383691core:AfterOneYear2022-10-012023-09-3010383691core:WithinOneYear2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:CostValuation2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-10-012023-09-3010383691core:Non-currentFinancialInstrumentscore:CostValuation2023-09-3010383691core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-3010383691core:Non-currentFinancialInstrumentscore:CostValuation2022-09-3010383691core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-09-3010383691core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-09-3010383691core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-09-3010383691core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-09-3010383691core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-09-3010383691core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-09-3010383691core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-09-3010383691bus:Director12022-10-012023-09-3010383691bus:Director22022-10-012023-09-3010383691bus:Director32022-10-012023-09-30

GDK MEDI UK LTD

Registered Number
10383691
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2023

GDK MEDI UK LTD
Company Information
for the year from 1 October 2022 to 30 September 2023

Directors

HUANG, Anli
HUANG, Xiaochun
YU, Qian

Registered Address

C/O Umc Accountants
314 Carshalton Road
Carshalton
SM5 3QB

Registered Number

10383691 (England and Wales)
GDK MEDI UK LTD
Balance Sheet as at
30 September 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets3227303
227303
Current assets
Debtors-76
Cash at bank and on hand95,74769,012
95,74769,088
Creditors amounts falling due within one year(78,208)(52,453)
Net current assets (liabilities)17,53916,635
Total assets less current liabilities17,76616,938
Net assets17,76616,938
Capital and reserves
Called up share capital1,0001,000
Profit and loss account16,76615,938
Shareholders' funds17,76616,938
The financial statements were approved and authorised for issue by the Board of Directors on 1 March 2024, and are signed on its behalf by:
HUANG, Xiaochun
Director
Registered Company No. 10383691
GDK MEDI UK LTD
Notes to the Financial Statements
for the year ended 30 September 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment25
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20232022
Average number of employees during the year22
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 October 221,500
At 30 September 231,500
Depreciation and impairment
At 01 October 221,197
Charge for year76
At 30 September 231,273
Net book value
At 30 September 23227
At 30 September 22303
4.Related party transactions
Transactions with directors mainly arose business expenses paid on behalf of the company. The company was under the control of Ms. X Huang throughout the current and previous financial years, Ms. Huang is the managing directors and majority shareholding of the company. No transactions with related parties were undertaken such as are required to be disclosed under FRS 102 Section 1A.